8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione

• Post Date:

  Jul 03,2025

• Expiry Date:

  Jul 03,2026

• Detailed Description:

  Cas No. :853029-57-9 Specs: 98%(HPLC)
  Intermediates of Linagliptin

• CAS Registry Number:

  853029-57-9

• Synonyms:

  ;1H-Purine-2,6-dione, 8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-;8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione;1H-Purine-2,6-dione, 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-;8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-Bromo-7-(2-Butyn-A-Yl)-3,7-Dihydro-3-Methyl-1-[(4-Methyl-2-Quinazolinyl)Methyl]-1H-Purine-2,6-Dione;8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-1h-purine-2,6-dione;8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione;

• Molecular Formula:

  C₂₀H₁₇BrN₆O₂

• Molecular Structure:

  

• Company:

  Shanghai DND Pharm-Technology Co., Inc.     [ China ]          

• Contact:

  Arron Yu

• Tel:

  021-58783620

• Fax:

  021-58783595

• Email:

  sales@dndpharm.com